State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now? [electronic resource]
- Anticancer research Jul 2019
- 3405-3412 p. digital
Publication Type: Journal Article; Review
1791-7530
10.21873/anticanres.13484 doi
Antineoplastic Agents--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use ErbB Receptors--antagonists & inhibitors Humans Immunotherapy Pancreatic Neoplasms--pathology Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use Vascular Endothelial Growth Factor A--antagonists & inhibitors